組織因子通道抑制因子(TFPI)真核蛋白
Eukaryotic Tissue Factor Pathway Inhibitor (TFPI)
TFI; EPI; LACI; TFPI1; Lipoprotein-Associated Coagulation Inhibitor; Extrinsic pathway inhibitor
- 編號UEPA394Hu62
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來源真核表達(dá)
- 宿主293F
- 內(nèi)毒素水平<1.0EU/µg(LAL法測定)
- 亞細(xì)胞定位分泌
- 預(yù)測分子量30.81kDa
- 實(shí)際分子量44kDa(差異分析請參閱說明書)
- 片段與標(biāo)簽Asp29~Met282 with N-terminal His Tag
- 緩沖液成份PBS, pH7.4, containing 5% Trehalose.
- 性狀凍干粉
- 純度> 80%
- 等電點(diǎn)6.6
-
應(yīng)用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請參見活性蛋白。 - 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 606 ¥ 1515 ¥ 3030 ¥ 9090 ¥ 22725
- 欲了解實(shí)際交易價格和更多情況，請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
序列
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復(fù)凍融。2-8°C不超過一個月，-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲，損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| UEPA394Hu62 | 組織因子通道抑制因子(TFPI)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UAPA394Hu02 | 組織因子通道抑制因子(TFPI)活性蛋白 | Cell?culture;?Activity?Assays. |
| UAPA394Hu03 | 組織因子通道抑制因子(TFPI)活性蛋白 | Cell?culture;?Activity?Assays. |
| URPA394Hu02 | 組織因子通道抑制因子(TFPI)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UAPA394Hu61 | 組織因子通道抑制因子(TFPI)活性蛋白 | Cell?culture;?Activity?Assays. |
| UEPA394Hu61 | 組織因子通道抑制因子(TFPI)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| URPA394Hu01 | 組織因子通道抑制因子(TFPI)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| URPA394Hu03 | 組織因子通道抑制因子(TFPI)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UPAA394Hu03 | 組織因子通道抑制因子(TFPI)多克隆抗體 | WB |
| UPAA394Hu01 | 組織因子通道抑制因子(TFPI)多克隆抗體 | WB; IHC; ICC; IP. |
| UPAA394Hu02 | 組織因子通道抑制因子(TFPI)多克隆抗體 | WB; IHC |
| ULAA394Hu71 | 組織因子通道抑制因子(TFPI)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| UMAA394Hu21 | 組織因子通道抑制因子(TFPI)單克隆抗體 | WB |
| UMAA394Hu26 | 組織因子通道抑制因子(TFPI)單克隆抗體 | WB |
| URAA394Hu64 | 組織因子通道抑制因子(TFPI)重組抗體 | WB; IF; ICC; IHC; IP; FCM. |
| UMAA394Hu22 | 組織因子通道抑制因子(TFPI)單克隆抗體 | WB; IHC; ICC; IP. |
| UMAA394Hu23 | 組織因子通道抑制因子(TFPI)單克隆抗體 | WB; IHC; ICC; IP. |
| ULAA394Hu72 | 組織因子通道抑制因子(TFPI)單克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| UWEA394Hu | 組織因子通道抑制因子(TFPI)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,寬范圍) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| USEA394Hu | 組織因子通道抑制因子(TFPI)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| UHEA394Hu | 組織因子通道抑制因子(TFPI)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法,高敏型) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| USCA394Hu | 組織因子通道抑制因子(TFPI)檢測試劑盒(化學(xué)發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
| ULMA394Hu | 組織因子通道抑制因子(TFPI)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| UPSA394Hu01 | 組織因子通道抑制因子(TFPI)抗體對 | ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays. |
| UKSA394Hu01 | 組織因子通道抑制因子(TFPI)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| South African Journal of Child Health | Tissue factor pathway inhibitor in paediatric patients with nephrotic syndrome [Sajch: 383] |
| the journal of immunology | Cathepsin G in Experimental Tuberculosis: Relevance for Antibacterial Protection and Potential for Immunotherapy [PubMed: 26320257] |
| Molecular Nutrition & Food Research | Trans‐fatty acid promotes thrombus formation in mice by aggravating antithrombogenic endothelial functions via Toll‐like receptors [PubMed: 25546502] |
| Molecular Carcinogenesis | Endothelial cell‐anchored tissue factor pathway inhibitor regulates tumor metastasis to the lung in mice [PubMed: 25945811] |
| Cell?Biology?International | Extracellular?vesicles?from?malignant?effusions?induce?tumor?cell?migration:?inhibitory?effect?ofLMWH?tinzaparin. [pubmed:27435911] |
| International Journal of Infectious Diseases | Kunitz-type protease inhibitor as a vaccine candidate against schistosomiasis mansoni [pubmed:29128645] |
留言咨詢
